title: Bone effects of space flight: analysis by quantum concept of bone remodelling.
abstract: During the manned Skylab flights mineral losses from the calcaneum and changes in external calcium balance were in the ranges found for healthy subjects at bedrest. Calcium balance reached a nadir of -200 mg/day by two months with no change thereafter; the negative balance was due to increased urinary excretion with no change in net absorption. The total calcium loss averaged 18 g in the longest flight of 84 days; the densitiometric data suggested that about two-thirds of this came from trabecular bone and about one-third from cortical bone. These data could represent reversible bone loss due to increased birth rate of normal osteoclasts and osteoblasts and consequent increase in bone turnover and in reversible mineral deficit, or irreversible bone loss due to overactive osteoclasts and/or underactive osteoblasts. If the former explanation is correct, significant bone loss is unlikely whatever the duration of future flights, except in older persons already losing bone; if the latter explanation is correct, space flights longer than six months may lead to a significant increase in fracture risk in later life. Neither terrestrial immobilization nor unwilling animals in orbit are ideal models for the effects of space flight on human bone. To choose between reversible and irreversible mechanisms of bone loss, and to determine the effects of space flight on lifelong fracture risk, future astronauts and cosmonauts must undergo adequate histologic study of bone after in vivo tetracycline labeling.
authors.affiliation: Bone and Mineral Research Laboratory, Henry Ford Hospital, Detroit, MI 48202, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Parfitt
mesh_terms: D015502:Absorptiometry, Photon; D000818:Animals; D000900:Anti-Bacterial Agents; D001510:Bed Rest; D018488:Bone Demineralization, Pathologic / Q000209:etiology / Q000503:physiopathology*; D015519:Bone Density / Q000502:physiology*; D016723:Bone Remodeling / Q000502:physiology*; D001862:Bone Resorption / Q000209:etiology / Q000503:physiopathology; D001842:Bone and Bones / Q000378:metabolism / Q000502:physiology / Q000503:physiopathology; D002118:Calcium / Q000378:metabolism*; D006801:Humans; D008297:Male; D051381:Rats; D013026:Space Flight; D013752:Tetracycline; D014893:Weightlessness / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D013752:Tetracycline; D002118:Calcium